Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
15°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Monday/Com Ltd
ServiceNow Inc
Mad Money
From
CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
Tags
Mad Money
S&P 500
Aehr Test Systems
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Eli Lilly and Co
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Europe News
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Weight management
Business
Pharmaceuticals
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Novo Nordisk A/S
Dexcom Inc
Alphabet Inc
From
CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
Tags
Advanced Micro Devices Inc
Consumer prices
Chevron Corp
From
CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Prices
Intel Corp
Inflation
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Investing
Investment strategy
Health & Science
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Walgreens Boots Alliance Inc
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Investing
Fast Money
Weight management
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Earnings
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
Benzinga
electric vehicles
TPST
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
U/S/ Markets
Business News
Abbott Laboratories
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Economy
Humana Inc
stocks
From
CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
Tags
Timken Co
Business
Breaking News: Markets
From
CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
October 11, 2023
Tags
Earnings
Europe Markets
Novo Nordisk A/S
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Consumer Finance
Retail industry
Stock markets
From
CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
October 10, 2023
Tags
Robinhood Markets Inc
Eli Lilly and Co
Block Inc
From
CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
October 05, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
Tags
Eli Lilly and Co
Piper Jaffray Companies
Clorox Co
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
October 01, 2023
Tags
PepsiCo Inc/
Health & Science
Hershey Co
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
September 29, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
September 19, 2023
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.